ESR1 and breast carcinoma: Given the remarkable effects of ATRA on inhibiting ERα, AKT, and ERK1/2, as well as cell proliferation in tamoxifen-resistant breast cancer in vitro, we next asked whether ATRA had therapeutic effect against TAMR breast tumors in vivo.